DE3149923A1 - 5-(aminoalkyl)-11-phenyl-5h-dibenzo(b,e), (1,4)diazepine, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, welche diese verbindungen enthalten - Google Patents

5-(aminoalkyl)-11-phenyl-5h-dibenzo(b,e), (1,4)diazepine, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, welche diese verbindungen enthalten

Info

Publication number
DE3149923A1
DE3149923A1 DE19813149923 DE3149923A DE3149923A1 DE 3149923 A1 DE3149923 A1 DE 3149923A1 DE 19813149923 DE19813149923 DE 19813149923 DE 3149923 A DE3149923 A DE 3149923A DE 3149923 A1 DE3149923 A1 DE 3149923A1
Authority
DE
Germany
Prior art keywords
dibenzo
diazepine
hydrogen
general formula
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19813149923
Other languages
German (de)
English (en)
Inventor
Chandler Roy 23111 Mechanicsville Va. Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AH Robins Co Inc
Original Assignee
AH Robins Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AH Robins Co Inc filed Critical AH Robins Co Inc
Publication of DE3149923A1 publication Critical patent/DE3149923A1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/38—[b, e]- or [b, f]-condensed with six-membered rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE19813149923 1981-09-24 1981-12-16 5-(aminoalkyl)-11-phenyl-5h-dibenzo(b,e), (1,4)diazepine, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, welche diese verbindungen enthalten Ceased DE3149923A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30507681A 1981-09-24 1981-09-24

Publications (1)

Publication Number Publication Date
DE3149923A1 true DE3149923A1 (de) 1983-04-14

Family

ID=23179221

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19813149923 Ceased DE3149923A1 (de) 1981-09-24 1981-12-16 5-(aminoalkyl)-11-phenyl-5h-dibenzo(b,e), (1,4)diazepine, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, welche diese verbindungen enthalten

Country Status (31)

Country Link
JP (1) JPS5865280A (ja)
KR (1) KR880001866B1 (ja)
AT (1) AT383121B (ja)
AU (2) AU549806B2 (ja)
BE (1) BE891535A (ja)
CA (1) CA1199325A (ja)
CH (2) CH651028A5 (ja)
DE (1) DE3149923A1 (ja)
DK (1) DK531281A (ja)
ES (1) ES8207157A1 (ja)
FI (1) FI813975L (ja)
FR (1) FR2513249B1 (ja)
GB (1) GB2106894B (ja)
GR (1) GR75123B (ja)
HK (1) HK85785A (ja)
HU (1) HU187394B (ja)
IE (1) IE51880B1 (ja)
IL (1) IL64257A (ja)
IN (1) IN155657B (ja)
IT (1) IT1146729B (ja)
LU (1) LU83798A1 (ja)
NL (1) NL8105892A (ja)
NO (1) NO813838L (ja)
NZ (1) NZ198986A (ja)
PH (1) PH16696A (ja)
PL (1) PL234420A1 (ja)
PT (1) PT74285B (ja)
SE (1) SE448453B (ja)
SG (1) SG65485G (ja)
YU (1) YU43070B (ja)
ZA (1) ZA818481B (ja)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB907646A (en) * 1959-01-23 1962-10-10 Wander S A A Method of production of new derivatives of diazepin
GB959994A (en) * 1959-09-22 1964-06-03 Wander S A A Basically substituted compounds and a process for their production

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT228215B (de) * 1959-01-23 1963-07-10 Wander Ag Dr A Verfahren zur Herstellung von neuen Diazepin-Derivaten
AT226721B (de) * 1959-09-22 1963-04-10 Wander Ag Dr A Verfahren zur Herstellung von neuen, 5-substituierten Diazepinen

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB907646A (en) * 1959-01-23 1962-10-10 Wander S A A Method of production of new derivatives of diazepin
GB959994A (en) * 1959-09-22 1964-06-03 Wander S A A Basically substituted compounds and a process for their production
DE1445180A1 (de) * 1959-09-22 1968-10-24 Wander Ag Dr A Verfahren zur Herstellung 5-basisch substiuierter 10,11-Dihydro-5 H-dibenzo [auf b,e] zu [auf 1,4] zu diazepine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CA 58:11385g *
CA 58:11386a *
FORTH, HENSCHLER, RUMMEL: Allgem. u. spez. Pharmakologie u. Toxikologie, 3. Aufl., B,I.-Wissenschaftsverlag, 1980, S. 453-455 *

Also Published As

Publication number Publication date
PT74285B (en) 1983-06-27
HU187394B (en) 1985-12-28
AU576010B2 (en) 1988-08-11
FR2513249B1 (fr) 1986-07-11
GR75123B (ja) 1984-07-13
ES507970A0 (es) 1982-09-01
FR2513249A1 (fr) 1983-03-25
AU549806B2 (en) 1986-02-13
JPS5865280A (ja) 1983-04-18
NO813838L (no) 1983-03-25
SG65485G (en) 1986-05-02
AU7851381A (en) 1983-03-31
JPH0315637B2 (ja) 1991-03-01
IL64257A (en) 1985-10-31
IT8168607A0 (it) 1981-12-10
IE51880B1 (en) 1987-04-15
CA1199325A (en) 1986-01-14
CH651028A5 (fr) 1985-08-30
IL64257A0 (en) 1982-02-28
GB2106894B (en) 1985-05-30
PL234420A1 (en) 1983-05-09
DK531281A (da) 1983-03-25
ES8207157A1 (es) 1982-09-01
NL8105892A (nl) 1983-04-18
SE448453B (sv) 1987-02-23
ZA818481B (en) 1982-10-27
YU43070B (en) 1989-02-28
YU62482A (en) 1984-12-31
CH657126A5 (fr) 1986-08-15
GB2106894A (en) 1983-04-20
AT383121B (de) 1987-05-25
ATA526981A (de) 1986-10-15
NZ198986A (en) 1986-02-21
KR830009057A (ko) 1983-12-17
BE891535A (fr) 1982-04-16
FI813975L (fi) 1983-03-25
PH16696A (en) 1984-01-06
IE812770L (en) 1983-03-24
AU4890585A (en) 1986-04-10
KR880001866B1 (ko) 1988-09-23
LU83798A1 (fr) 1983-09-01
IN155657B (ja) 1985-02-16
HK85785A (en) 1985-11-08
IT1146729B (it) 1986-11-19
PT74285A (en) 1982-02-01
SE8106594L (sv) 1983-03-25

Similar Documents

Publication Publication Date Title
EP0005205B1 (de) Substituierte 5,6-Dimethylpyrrolo(2,3-d)pyrimidine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP0103833B1 (de) Diazabicyclo-(3,3,1)-nonane
DE2915318A1 (de) Cycloalkyltriazole, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
CH643736A5 (de) Pharmazeutische zubereitungen, enthaltend imidazolderivate oder deren salze.
DE2818672A1 (de) Alpha-(1-r-3-azetidinyl)-alpha- phenyl-alpha-substituierte-acetamide oder -acetonitrile, verfahren zu ihrer herstellung und verwendung zur behandlung von herzarrhythmien
EP0044989B1 (de) Neue, in 5-Stellung substituierte 5,10-Dihydro-11H-dibenzo (b,e)(1,4)diazepin-11-one, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0163260A1 (de) Neue substituierte Pyrrolidinone, Verfahren zu ihrer Herstellung und Arzneimittel
EP0213293B1 (de) In 11-Stellung substituierte 5,11-Dihydro-6H-pyrido-[2,3-b][1,4]benzodiazepin-6-one, Verfahren zur ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3037313A1 (de) Heterocyclische verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE1670305B2 (de) 5-Phenyl-2,4-dioxo-1,2,3,4-tetrahydro-3H-1,5-benzodiazepine und Verfahren zu ihrer Herstellung
DE2229845B2 (de) 6-o-Halogenphenyl-4H-s-triazolo [3,4-c] thieno [2,3e] [1,4] diazepine, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Massen
DE2719607C2 (ja)
CH618433A5 (ja)
DE3149923A1 (de) 5-(aminoalkyl)-11-phenyl-5h-dibenzo(b,e), (1,4)diazepine, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, welche diese verbindungen enthalten
EP0280290B1 (de) Mittel mit antidepressiver Wirkung
EP0050212A1 (de) 5-Substituierte 9-Cyanmethylen-dithieno(3,4-b:4'.3'-e)-azepine, Verfahren zu ihrer Herstellung und diese enthaltende therapeutische Mittel
EP0172526B1 (de) Neue Benzodiazepine, Verfahren zu ihrer Herstellung sowie ihre Verwendung
EP0086980B1 (de) Substituierte Dibenzodiazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3523002A1 (de) Neue in 11-stellung substituierte 5,11-dihydro-6h-pyrido(2,3-b) (1,4)benzodiazepin-6-one, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2435816B2 (de) Substituierte nitrobenzophenonderivate, ihre salze, verfahren zur herstellung derselben und arzneimittel
DE3204401A1 (de) Pyridobenzodiazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0266563B1 (de) Verwendung von 1-Benzyl-amino-alkyl-pyrrolidinonen als Antidepressiva
DE2827617A1 (de) Neue imidazo eckige klammer auf 1,2- alpha eckige klammer zu imidazole, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
DE1793590C3 (de) N-Cyclopropyl-N-propargyl- 1-aminoindan, dessen Salze und Arzneimittel auf dieser Grundlage. Ausscheidung aus': 1443403
DE1966815C3 (de) Pyrido [2,3-b] [1,4] benzodiazepinderivate

Legal Events

Date Code Title Description
8128 New person/name/address of the agent

Representative=s name: SCHWABE, H., DIPL.-ING. SANDMAIR, K., DIPL.-CHEM.

8110 Request for examination paragraph 44
8131 Rejection